417 related articles for article (PubMed ID: 15099329)
1. Mohs micrographic surgery of primary cutaneous mucinous carcinoma using immunohistochemistry for margin control.
Marra DE; Schanbacher CF; Torres A
Dermatol Surg; 2004 May; 30(5):799-802. PubMed ID: 15099329
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous mucinous carcinoma: report of two cases treated with Mohs' micrographic surgery.
Cecchi R; Rapicano V
Australas J Dermatol; 2006 Aug; 47(3):192-4. PubMed ID: 16867002
[TBL] [Abstract][Full Text] [Related]
3. Innovative 19-minute rapid cytokeratin immunostaining of nonmelanoma skin cancer in Mohs micrographic surgery.
Cherpelis BS; Turner L; Ladd S; Glass LF; Fenske NA
Dermatol Surg; 2009 Jul; 35(7):1050-6. PubMed ID: 19469800
[TBL] [Abstract][Full Text] [Related]
4. The use of antidesmoglein stains in Mohs micrographic surgery. A potential aid for the differentiation of basal cell carcinoma from horizontal sections of the hair follicle and folliculocentric basaloid proliferation.
Krunic AL; Garrod DR; Viehman GE; Madani S; Buchanan MD; Clark RE
Dermatol Surg; 1997 Jun; 23(6):463-8. PubMed ID: 9217798
[TBL] [Abstract][Full Text] [Related]
5. Rapid HMB-45 staining in Mohs micrographic surgery for melanoma in situ and invasive melanoma.
Menaker GM; Chiang JK; Tabila B; Moy RL
J Am Acad Dermatol; 2001 May; 44(5):833-6. PubMed ID: 11312433
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous head and neck melanoma treated with Mohs micrographic surgery.
Bricca GM; Brodland DG; Ren D; Zitelli JA
J Am Acad Dermatol; 2005 Jan; 52(1):92-100. PubMed ID: 15627086
[TBL] [Abstract][Full Text] [Related]
7. Recurrent and metastatic primary cutaneous mucinous carcinoma after excision and Mohs micrographic surgery.
Tam CC; Dare DM; DiGiovanni JJ; Harrington AC; Deng AC
Cutis; 2011 May; 87(5):245-8. PubMed ID: 21699128
[TBL] [Abstract][Full Text] [Related]
8. Current progress of immunostains in Mohs micrographic surgery: a review.
Thosani MK; Marghoob A; Chen CS
Dermatol Surg; 2008 Dec; 34(12):1621-36. PubMed ID: 19018832
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical stains in Mohs surgery: a review.
Stranahan D; Cherpelis BS; Glass LF; Ladd S; Fenske NA
Dermatol Surg; 2009 Jul; 35(7):1023-34. PubMed ID: 19397647
[TBL] [Abstract][Full Text] [Related]
10. Primary mucinous carcinoma with direct histopathologic evidence of lymphatic invasion.
Warycha M; Kamino H; Mobini N; Hale EK
J Drugs Dermatol; 2006; 5(7):655-8. PubMed ID: 16865872
[TBL] [Abstract][Full Text] [Related]
11. A comparison of touch imprint cytology and Mohs frozen-section histology in the evaluation of Mohs micrographic surgical margins.
Florell SR; Layfield LJ; Gerwels JW
J Am Acad Dermatol; 2001 Apr; 44(4):660-4. PubMed ID: 11260543
[TBL] [Abstract][Full Text] [Related]
12. Basal cell carcinoma: rapid techniques using cytokeratin markers to assist treatment by micrographic (Mohs') surgery.
Ramnarain ND; Walker NP; Markey AC
Br J Biomed Sci; 1995 Sep; 52(3):184-7. PubMed ID: 8527995
[TBL] [Abstract][Full Text] [Related]
13. The 20-minute rapid MART-1 immunostain for malignant melanoma frozen sections.
Kimyai-Asadi A; Ayala GB; Goldberg LH; Vujevich J; Jih MH
Dermatol Surg; 2008 Apr; 34(4):498-500. PubMed ID: 18248466
[TBL] [Abstract][Full Text] [Related]
14. Who should have Mohs micrographic surgery?
Perkins W
Curr Opin Otolaryngol Head Neck Surg; 2010 Aug; 18(4):283-9. PubMed ID: 20613530
[TBL] [Abstract][Full Text] [Related]
15. [Microcystic adnexal carcinoma: Mohs micrographic surgery as the treatment of choice].
Martorell-Calatayud A; Requena-Caballero C; Botella-Estrada R; Almenar-Medina S; Sanmartín-Jiménez O; Llombart-Cussac B; Nagore-Enguídanos E; Serra-Guillén C; Echeverría-García B; Guillén-Barona C
Actas Dermosifiliogr; 2009 Oct; 100(8):693-9. PubMed ID: 19775547
[TBL] [Abstract][Full Text] [Related]
16. Current concepts: the use of immunoperoxidase techniques in mohs micrographic surgery.
Mondragon RM; Barrett TL
J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):66-71. PubMed ID: 10863226
[TBL] [Abstract][Full Text] [Related]
17. Margin involvement after the excision of melanoma in situ: the need for complete en face examination of the surgical margins.
Kimyai-Asadi A; Katz T; Goldberg LH; Ayala GB; Wang SQ; Vujevich JJ; Jih MH
Dermatol Surg; 2007 Dec; 33(12):1434-9; discussion 1439-41. PubMed ID: 18076608
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of narrow-margin excision of well-demarcated primary facial basal cell carcinomas.
Kimyai-Asadi A; Alam M; Goldberg LH; Peterson SR; Silapunt S; Jih MH
J Am Acad Dermatol; 2005 Sep; 53(3):464-8. PubMed ID: 16112354
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of serial transverse cross-sections in detecting residual basal cell carcinoma at the surgical margins of an elliptical excision specimen.
Kimyai-Asadi A; Goldberg LH; Jih MH
J Am Acad Dermatol; 2005 Sep; 53(3):469-74. PubMed ID: 16112355
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical techniques in Mohs micrographic surgery: their potential use in the detection of neoplastic cells masked by inflammation.
Jimenez FJ; Grichnik JM; Buchanan MD; Clark RE
J Am Acad Dermatol; 1995 Jan; 32(1):89-94. PubMed ID: 7529778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
